Immunity to Listeria infection

Current Opinion in Immunology

Volumn 12, Issue 4, 2000, Pages 425-431

  Edelson, Brian T ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

HOST RESISTANCE; IMMUNITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; REVIEW; T LYMPHOCYTE;

EID: 0034095569     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00112-6     Document Type: Review

References (77)

1. Parham P. Immunity to Listeria monocytogenes: a model intracellular pathogen. Immunol Rev. 158:1997;1-221.
2. Cossart P., Lecuit M. Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signalling. EMBO J. 17:1998;3797-3806.
3. Lecuit M., Dramsi S., Gottardi C., Fedor-Chaiken M., Gumbiner B., Cossart P. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J. 18:1999;3956-3963.
4. Gaillard J.L., Berche P., Mounier J., Richard S., Sansonetti P. In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect Immun. 55:1987;2822-2829.
5. Portnoy D.A., Jacks P.S., Hinrichs D.J. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med. 167:1988;1459-1471.
6. Tilney L.G., Portnoy D.A. Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite Listeria monocytogenes. J Cell Biol. 109:1989;1597-1608.
7. Rogers H.W., Unanue E.R. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun. 61:1993;5090-5096.
8. Czuprynski C.J., Brown J.F., Maroushek N., Wagner R.D., Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol. 152:1994;1836-1846.
9. Czuprynski C.J., Brown J.F., Wagner R.D., Steinberg H. Administration of antigranulocyte monoclonal antibody RB6-8C5 prevents expression of acquired resistance to Listeria monocytogenes infection in previously immunized mice. Infect Immun. 62:1994;5161-5163.
10. Conlan J.W., North R.J. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med. 179:1994;259-268.
11. Rakhmilevich A.L. Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes. J Leukoc Biol. 57:1995;827-831.
12. Rogers H.W., Callery M.P., Deck B., Unanue E.R. Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol. 156:1996;679-684.
13. Unanue E.R. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr Opin Immunol. 9:1997;35-43.
14. Bancroft G.J., Schreiber R.D., Unanue E.R. Natural immunity: a T-cell independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev. 124:1991;5-24.
15. Beckerman K.P., Rogers H.W., Corbett J.A., Schreiber R.D., McDaniel M.L., Unanue E.R. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol. 150:1993;888-895.
16. -/- double-deficient mice are susceptible to Listeria infection. Macrophages from these mice are extremely deficient in killing wild-type Listeria in vitro although these cells can perform limited killing of an attenuated strain of Listeria.
17. Ohteki T., Fukao T., Suzue K., Maki C., Ito M., Nakamura M., Koyasu S. Interleukin 12-dependent interferon γ production by CD8α+ lymphoid dendritic cells. J Exp Med. 189:1999;1981-1986.
18. Unanue E.R. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol Rev. 158:1997;11-25.
19. Meraz M.A., White J.M., Sheehan K.C.F., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D.et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:1996;431-442.
20. Fehr T., Schoedon G., Odermatt B., Holtschke T., Schneemann M., Bachmann M.F., Mak T.W., Horak I., Zinkernagel R.M. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J Exp Med. 185:1997;921-931.
21. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 287:2000;860-864. This study demonstrates that the T cell cytokine Eta-1 regulates macrophage production of IL-12 and IL-10, and is an important cytokine for the development of cell-mediated immunity. Eta-1 deficient mice are susceptible to Listeria infection.
22. Pamer E.G., Harty J.T., Bevan M.J. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature. 353:1991;852-855.
23. Sijts A.J., Neisig A., Neefjes J., Pamer E.G. Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J Immunol. 156:1996;683-692.
24. Busch D.H., Bouwer H.G., Hinrichs D., Pamer E.G. A nonamer peptide derived from Listeria monocytogenes metalloprotease is presented to cytolytic T lymphocytes. Infect Immun. 65:1997;5326-5329.
25. Darji A., Bruder D., zur Lage S., Gerstel B., Chakraborty T., Wehland J., Weiss S. The role of the bacterial membrane protein ActA in immunity and protection against Listeria monocytogenes. J Immunol. 161:1998;2414-2420.
26. Safley S.A., Cluff C.W., Marshall N.E., Ziegler H.K. Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes. Identification of T cell epitopes of LLO. J Immunol. 146:1991;3604-3616.
27. Sanderson S., Campbell D.J., Shastri N. Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning. J Exp Med. 182:1995;1751-1757.
28. Campbell D.J., Shastri N. Bacterial surface proteins recognized by CD4+ T cells during murine infection with Listeria monocytogenes. J Immunol. 161:1998;2339-2347.
29. Geginat G., Lalic M., Kretschmar M., Goebel W., Hof H., Palm D., Bubert A. Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J Immunol. 160:1998;6046-6055.
30. Lenz L.L., Dere B., Bevan M.J. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity. 5:1996;63-72.
31. Gulden P.H., Fischer P., Sherman N.E., Wang W., Engelhard V.H., Shabanowitz J., Hunt D.F., Pamer E.G. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity. 5:1996;73-79.
32. Princiotta M.F., Lenz L.L., Bevan M.J., Staerz U.D. H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med. 187:1998;1711-1719.
33. Busch D.H., Pilip I.M., Vijh S., Pamer E.G. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity. 8:1998;353-362.
34. Busch D.H., Kerksiek K., Pamer E.G. Processing of Listeria monocytogenes antigens and the in vivo T-cell response to bacterial infection. Immunol Rev. 172:1999;163-169.
35. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
36. Ochsenbein A.F., Karrer U., Klenerman P., Althage A., Ciurea A., Shen H., Miller J.F., Whitton J.L., Hengartner H., Zinkernagel R.M. A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci USA. 96:1999;9293-9298.
37. Kagi D.B., Ledermann B., Burki K., Hengartner H., Zinkernagel R.M. CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol. 24:1994;3068-3072.
38. White D.W., Harty J.T. Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-γ but requires TNF-α J Immunol. 160:1998;898-905.
39. Harty J.T., Bevan M.J. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity. 3:1995;109-117.
40. Bhardwaj V., Kanagawa O., Swanson P.E., Unanue E.R. Chronic Listeria infection in SCID mice: requirements for the carrier state and the dual roles of T cells in transferring protection or suppression. J Immunol. 160:1998;376-384.
41. + T cells during primary infection but show a limited recall response.
42. Mackaness G.B. Cellular resistance to infection. J Exp Med. 116:1962;381-406.
43. Miki K., Mackaness G.B. The passive transfer of acquired resistance to Listeria monocytogenes. J Exp Med. 120:1964;93-103.
44. Mackaness G.B. The immunological basis of acquired cellular resistance. J Exp Med. 120:1964;105-120.
45. Mackaness G.B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 129:1969;973-992.
46. Lane F.C., Unanue E.R. Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med. 135:1972;93-104.
47. Blanden R.V., Langman R.E. Cell-mediated immunity to bacterial infection in the mouse. Thymus-derived cells as effectors of acquired resistance to Listeria monocytogenes. Scand J Immunol. 1:1972;379-388.
48. North R.J. The mediators of anti-Listeria immunity as an enlarged population of short-lived replicating T cells: kinetics of their production. J Exp Med. 138:1973;342-350.
49. Casadevall A. Antibody-mediated protection against intracellular pathogens. Trends Microbiol. 6:1998;102-107.
50. Nussbaum G., Cleare W., Casadevall A., Scharff M.D., Valadon P. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med. 185:1997;685-694.
51. Yuan R., Casadevall A., Spira G., Scharff M.D. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol. 154:1995;1810-1816.
52. Yuan R., Casadevall A., Oh J., Ravetch J.V., Scharff M.D. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med. 187:1998;641-648.
53. Yuan R., Casadevall A., Oh J., Scharff M.D. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Natl Acad Sci USA. 94:1997;2483-2488.
54. Eisenstein T.K., Killar L.M., Sultzer B.M. Immunity to infection with Salmonella typhimurium: mouse strain differences in vaccine- and serum-mediated protection. J Infect Dis. 150:1984;425-435.
55. Glatman-Freedman A., Casadevall A. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev. 11:1998;514-532.
56. Teitelbaum R., Glatman-Freedman A., Chen B., Robbins J.B., Unanue E., Casadevall A., Bloom B.R. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA. 95:1998;15688-15693.
57. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., Zinkernagel R.M. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 286:1999;2156-2159. This study analyzes, for the first time, the role of natural IgM in the early distribution of virus (VSV and LCMV) or Listeria throughout the host. Natural antibody increases pathogen localization to the spleen, limiting the extent of infection in peripheral organs. The mechanism whereby IgM alters organ distribution is not established although it does not depend on complement.
58. Edelson B.T., Cossart P., Unanue E.R. Paradigm revisited: antibody provides resistance to Listeria infection. J Immunol. 163:1999;4087-4090. This study demonstrates, for the first time, the ability of a neutralizing mAb against LLO, the pore-forming toxin of Listeria, to provide resistance to Listeria infection in vivo.
59. Bancroft G.J., Bosma M.J., Bosma G.C., Unanue E.R. Regulation of macrophage Ia expression in mice with severe combine immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol. 137:1986;4-9.
60. Guzman C.A., Domann E., Rohde M., Bruder D., Darji A., Weiss S., Wehland J., Chakraborty T., Timmis K.N. Apoptosis of mouse dendritic cells is triggered by listeriolysin, the major virulence determinant of Listeria monocytogenes. Mol Microbiol. 20:1996;119-126.
61. Tang P., Rosenshine I., Cossart P., Finlay B.B. Listeriolysin O activates mitogen-activated protein kinase in eucaryotic cells. Infect Immun. 64:1996;2359-2361.
62. Kayal S., Lilienbaum A., Poyart C., Memet S., Israel A., Berche P. Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines. Mol Microbiol. 31:1999;1709-1722.
63. Sibelius U., Rose F., Chakraborty T., Darji A., Wehland J., Weiss S., Seeger W., Grimminger F. Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells. Infect Immun. 64:1996;674-676.
64. Nishibori T., Xiong H., Kawamura I., Arakawa M., Mitsuyama M. Induction of cytokine gene expression by listeriolysin O and roles of macrophages and NK cells. Infect Immun. 64:1996;3188-3195.
65. Sibelius U., Schulz E.C., Rose F., Hattar K., Jacobs T., Weiss S., Chakraborty T., Seeger W., Grimminger F. Role of Listeria monocytogenes exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C in activation of human neutrophils. Infect Immun. 67:1999;1125-1130.
66. Coconnier M.H., Dlissi E., Robard M., Laboisse C.L., Gaillard J.L., Servin A.L. Listeria monocytogenes stimulates mucus exocytosis in cultured human polarized mucosecreting intestinal cells through action of listeriolysin O. Infect Immun. 66:1998;3673-3681.
67. Merrick J.C., Edelson B.T., Bhardwaj V., Swanson P.E., Unanue E.R. Lymphocyte apoptosis during early phase of Listeria infection in mice. Am J Pathol. 151:1997;785-792.
68. Hage-Chahine C.M., Del Giudice G., Lambert P.H., Pechere J.C. Hemolysin-producing Listeria monocytogenes affects the immune response to T-cell-dependent and T-cell-independent antigens. Infect Immun. 60:1992;1415-1421.
69. Gauduin M.C., Parren P.W., Weir R., Barbas C.F., Burton D.R., Koup R.A. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat Med. 3:1997;1389-1393.
70. •].
71. •].
72. •].
73. •].
74. •] show that neutralizing antibodies to HIV and Ebola virus can provide resistance to these infections in animal models. For both of these viruses, natural infection results in very little neutralizing antibody. Nevertheless, in both cases, use of appropriate mAbs has demonstrated antibody to be a powerful means of protection.
75. Burton D.R., Parren P.W.H.I. Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection? Nat Med. 6:2000;123-125.
76. Kuhn M., Pfeuffer T., Greiffenberg L., Goebel W. Host cell signal transduction during Listeria monocytogenes infection. Arch Biochem Biophys. 372:1999;166-172.
77. Braun L., Ghebrehiwet B., Cossaert P. gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J. 19:2000;1458-1466.